20:22 EDT Cathie Wood’s ARK Investment bought 119K shares of Intellia Therapeutics today
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTLA:
- Intellia Therapeutics price target raised to $90 from $73 at Canaccord
- Intellia Therapeutics price target lowered to $31 from $32 at Goldman Sachs
- Intellia Therapeutics price target lowered to $54 from $60 at RBC Capital
- Intellia Therapeutics sees cash runway into late 2026
- Intellia Therapeutics announces topline results from Phase study of NTLA-2002
Questions or Comments about the article? Write to editor@tipranks.com